Southeast Cancer Control Consortium, Inc., CCOP
Principal Investigator: Dr. James N. Atkins • Administrator: Susan Tuttle, RN, CCRP • SCCC Operations Office, 2150 Country Club Road, Suite 200, Winston-Salem, NC 27104 • Phone: 366-777-3036 • Web site: http://www.southeastcancercontrol.org
SCCC includes 122 physicians, among them oncologists, surgeons, urologists, and radiation oncologists. Its operations office is located in Winston-Salem and is staffed by five employees who oversee the daily functions of the program.
SCCC's mission is to offer clinical trials aimed at cancer prevention and control in the communities it serves, thus improving the quality of cancer treatment, reducing incidence through education, and reducing morbidity and mortality through early diagnosis.
Recruitment and Outreach Activities
Accrual to clinical trials for minority populations is challenging, but on average, SCCC achieves a 15-percent minority enrollment for its trials. Minority nurse recruiters have been used in several communities to provide cancer education and promote clinical trial research.
In addition to its funding as an NCI CCOP, SCCC collaborates with eight NCI-funded clinical trial cooperative group research bases, including the National Surgical Adjuvant Breast and Bowel Project, for which it is the highest accruing CCOP for treatment studies; the Cancer and Leukemia Group B, for which it is the second-highest accruing CCOP overall; and the Southwest Oncology Group, in which SCCC recruits patients for cancer-treatment and cancer-control studies. Other research affiliations are with the Radiation Therapy Oncology Group, the Cancer Trials Support Unit, the University of Rochester Cancer Center, the University of Michigan Cancer Center, and the Comprehensive Cancer Center of Wake Forest University. SCCC receives its clinical trial protocols and processes the resulting data through the eight research bases; patients are recruited to clinical trials through the CCOP itself.
Other Key Facts
This year, Dr. Atkins was recognized for his outstanding contribution as a community investigator by the Association for Community Cancer Centers, and in March, he received the NCI Harry Hynes Award for outstanding dedication and commitment in bringing clinic trials to the community.